Pancreatic cancer remains one of the most formidable challenges in modern oncology, yet the field is entering a defining era of scientific acceleration and therapeutic innovation. The AACR Conference on Pancreatic Cancer will convene a global community of leading researchers, clinicians, industry pioneers, and translational scientists to shape the future of pancreatic cancer research and redefine what is possible for patients facing this devastating disease.
Hosted in San Diego, California, for the first time, the conference reflects the increasingly global, multidisciplinary, and innovation-driven nature of the pancreatic cancer landscape. Against a backdrop of rapid advances in precision oncology, KRAS-targeted therapeutics, computational and AI-driven approaches, immunotherapy, and translational clinical research, the meeting will serve as a catalyst for the next generation of scientific discovery, clinical strategy, and cross-sector collaboration.
Designed to bridge transformative science with real-world clinical impact, the conference will provide an unparalleled forum for unveiling breakthrough discoveries, challenging conventional thinking, fostering meaningful partnerships, and advancing bold new approaches to drug development, clinical trial design, and patient care. By bringing together leaders across academia, biotechnology, pharmaceutical development, and regulatory science, the AACR Conference on Pancreatic Cancer aims not only to reflect the momentum of the field but to actively shape its future.
